Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.875 GBX | 0.00% | -12.96% | -32.86% |
Apr. 24 | EARNINGS AND TRADING: Nichols trading in line; Ondine revenue doubles | AN |
Apr. 22 | Ondine Biomedical celebrates use of Steriwave in Australian hospital | AN |
Sales 2023 * | 1.18M 865K | Sales 2024 * | 2.6M 1.9M | Capitalization | 22.72M 16.6M |
---|---|---|---|---|---|
Net income 2023 * | -15M -10.96M | Net income 2024 * | -18M -13.16M | EV / Sales 2023 * | 18.3 x |
Net cash position 2023 * | 1.1M 804K | Net cash position 2024 * | 3.8M 2.78M | EV / Sales 2024 * | 7.28 x |
P/E ratio 2023 * |
-1.25
x | P/E ratio 2024 * |
-2.03
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 22.43% |
Latest transcript on Ondine Biomedical Inc.
1 week | -12.96% | ||
Current month | -36.49% | ||
1 month | -39.74% | ||
3 months | -44.05% | ||
6 months | -44.05% | ||
Current year | -32.86% |
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 21-12-06 |
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.875 | 0.00% | 57,116 |
24-04-25 | 5.875 | -6.00% | 431,829 |
24-04-24 | 6.25 | -7.41% | 553,436 |
24-04-23 | 6.75 | -3.57% | 30,379 |
24-04-22 | 7 | +3.70% | 299,374 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.86% | 16.59M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- OBI Stock